Hemogenyx
HEMO.LHemogenyx Pharmaceuticals Plc Price (HEMO.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,129,136,727
(15.2475)%Cash Flow Statement
Hemogenyx Pharmaceuticals PlcCurrency: GBp
| YEAR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | -6,270.00
+0% |
-180.88
-97% |
-519,898.00
+287,334% |
-2,361,599.00
+354% |
-1,477,532.00
-37% |
-1,453,144.00
-2% |
-2,095,023.00
+44% |
-5,108,310.00
+144% |
-3,986,982.00
-22% |
-6,690,678.00
+68% |
|||||||||
| Depreciation And Amortiz... | 0.00 | 0.00 | 11.87 | 33.61k | 51.81k | 94.73k | 106.75k | 126.34k | 195.25k | 645.68k | |||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.75k | -146,772.00 | -18,025.00 | 0.00 | 0.00 | |||||||||
| Stock-Based Compensat... | 0.00 | 55.27 | 80.00k | 35.49k | 242.53k | 122.49k | 363.10k | 153.36k | 17.58k | 242.84 | |||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | -41.45 | -163.21 | 86.26k | -19,266.00 | 16.06k | -21,397.00 | -196,683.00 | -2,109.00 | 4.47k | |||||||||
| Accounts Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -35,738.00 | 298.07k | -27,120.00 | 0.00 | |||||||||
| Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other Working Capital | 0.00 | 0.00 | 0.00 | 6.49k | -98,670.00 | -17,880.00 | 623.00 | 0.00 | 271.82k | -838,065.00 | |||||||||
| Other Non-Cash Items | 0.00 | 246.77 | 81.68 | 1.92M | -51,595.00 | 17.14k | 30.05k | 2.12M | 620.97k | 772.78k | |||||||||
| Net Cash Provided By Op... | -6,270.00
+0% |
79.71
-101% |
-278,146.00
-349,059% |
-452,979.00
+63% |
-1,352,728.00
+199% |
-1,199,873.00
-11% |
-1,798,404.00
+50% |
-2,627,298.00
+46% |
-2,910,604.00
+11% |
-6,105,570.00
+110% |
|||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | 0.00 | 0.00 | -188.79 | -64,257.00 | -24,589.00 | -11,918.00 | -173,047.00 | -817,998.00 | -428,945.00 | -117,285.00 | |||||||||
| Acquisitions Net | 0.00 | 0.00 | 0.00 | 1.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -138,913.00 | -1,908.00 | 0.00 | |||||||||
| Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other Investing Activities | 0.00 | -235.64 | 0.22 | -279.00 | 4.37k | 14.19k | 3.37k | 17.96k | 10.60k | 85.34k | |||||||||
| Net Cash Used For Inv... | 0.00
+0% |
-235.64
+0% |
-188.57
-20% |
1.03M
-548,498% |
-20,221.00
-102% |
2.27k
-111% |
-169,682.00
-7,565% |
-938,953.00
+453% |
-420,254.00
-55% |
-31,941.00
-92% |
|||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | 0.00 | 0.00 | 0.00 | -154,422.00 | 1.18M | 0.00 | 3.61M | 8.82M | 0.00 | 0.00 | |||||||||
| Common Stock Issued | 12.50k | 0.00 | 754.91k | 2.00M | 4.99k | 0.00 | 35.07k | 12.00M | 0.00 | 5.09M | |||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Other Financing Activities | 0.00 | 203.43 | 0.00 | -628,871.00 | 0.00 | -39,393.00 | -433,024.00 | -12,039,079.00 | -110,144.00 | -638,765.00 | |||||||||
| Net Cash Used/Provide... | 12.50k
+0% |
203.43
-98% |
754.91
+271% |
1.22M
+161,072% |
1.18M
-3% |
-39,393.00
-103% |
3.21M
-8,254% |
8.78M
+173% |
-110,144.00
-101% |
4.45M
-4,140% |
|||||||||
| Effect Of Forex Changes... | 0.00 | 0.00 | 13.98 | -8,400.00 | 77.81k | -26,756.00 | 69.68k | -182,719.00 | -876,209.00 | 403.04k | |||||||||
| Net Change In Cash | 6.23k | 47.50 | -278,146.00 | 1.79M | -114,227.00 | -1,263,749.00 | 1.31M | 5.03M | -4,308,211.00 | -1,285,157.00 | |||||||||
| Cash At Beginning Of Per... | 0.00 | 0.07 | 1.32M | 87.22k | 1.88M | 1.76M | 498.68k | 1.81M | 6.84M | 2.53M | |||||||||
| Cash At End Of Period | 6.23k | 47.57 | 1.05M | 1.88M | 1.76M | 498.68k | 1.81M | 6.84M | 2.53M | 1.25M | |||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | -6,270.00 | 79.71 | -278,146.00 | -452,979.00 | -1,352,728.00 | -1,199,873.00 | -1,798,404.00 | -2,627,298.00 | -2,910,604.00 | -6,105,570.00 | |||||||||
| Capital Expenditure | 0.00 | 0.00 | -188.79 | -64,257.00 | -24,589.00 | -11,918.00 | -173,047.00 | -817,998.00 | -428,945.00 | -117,285.00 | |||||||||
| Free Cash Flow | -6,270.00
+0% |
79.71
-101% |
-278,334.79
-349,296% |
-517,236.00
+86% |
-1,377,317.00
+166% |
-1,211,791.00
-12% |
-1,971,451.00
+63% |
-3,445,296.00
+75% |
-3,339,549.00
-3% |
-6,222,855.00
+86% |
|||||||||